/DGX
Quest Diagnostics Incorporated
DGX • NYSEDGX • NYSE • Healthcare
$199.70-0.59%-1.18
$199.70-0.59%(-1.18)Healthcare
GoAI Score
Sign in to unlock
Valuation
50Fair Value
Sentiment
69Bullish
Risk
95Low Risk
Momentum
69Positive
Institutional-Grade Intelligence
🏆PRO
Actionable Intelligence
AI-driven stance, execution logic & risk thresholds
Catalyst Roadmap
Event timeline with expected impact & market context
Deep Insights
Fact-checked analysis & score logic breakdown
Financial Statements
Margin Trends
Gross
31.9%▼0.9pp
Revenue after COGS
Operating
14.5%▲0.9pp
After operating expenses
Net
9.0%▲0.2pp
Bottom-line profitability
Gross Margin
Operating Margin
Net Margin
Valuation Snapshot
P/E Ratio
19.4
Price vs earnings
EV/EBITDA
11.7
Enterprise value
FCF Yield
7.1%
Cash generation
Earnings Yield
5.2%
Inverse of P/E
Capital Efficiency
10
GoAI Quality ScoreFair
ROEReturn on Equity
13.8%Fair
ROAReturn on Assets
6.1%Strong
ROICReturn on Invested Capital
8.4%Fair
Financial Health
Current RatioAdequate
1.04
Short-term solvency (>1.5)
Net Debt / EBITDAManageable
2.96x
Debt repayment capacity (<3x)
Income QualityStrong
1.80
Cash backs earnings (>1)
Revenue & Profitability
Revenue
Net Income
Net Loss
Income Statement
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $11.04B | $9.87B | $9.25B | $9.88B | $10.79B |
| Gross Profit | $3.52B | $3.24B | $3.07B | $3.43B | $4.21B |
| Gross Margin | 31.9% | 32.9% | 33.2% | 34.7% | 39.0% |
| Operating Income | $1.60B | $1.35B | $1.26B | $1.43B | $2.38B |
| Net Income | $992.00M | $871.00M | $854.00M | $946.00M | $2.00B |
| Net Margin | 9.0% | 8.8% | 9.2% | 9.6% | 18.5% |
| EPS | $8.87 | $7.80 | $7.59 | $8.12 | $15.90 |
Average Price Target
$215.10▲ 7.7% Upside
Past 12 Months
12 Month Forecast
Based on 50 Wall Street analysts offering 12 month price targets for Quest Diagnostics Incorporated, the average price target is $215.10, with a high forecast of $235.00 and a low forecast of $200.00. The average price target represents a 7.7% increase from the current price of $199.70.
Highest
$235.00
Average
$215.10
Lowest
$200.00
Rating Distribution
Strong Buy
0
0%
Buy
13
38%
Hold
18
53%
Sell
3
9%
Strong Sell
0
0%
Recent Analyst Ratings
FirmActionRatingDate
Mizuho● Maintain
Outperform
2026-02-12UBS● Maintain
Neutral
2026-02-11Barclays● Maintain
Overweight
2026-02-11Truist Securities● Maintain
Hold
2026-02-11Jefferies● Maintain
Buy
2026-02-11Evercore ISI Group● Maintain
In Line
2026-02-11Citigroup● Maintain
Neutral
2026-02-10Piper Sandler● Maintain
Neutral
2025-10-27Barclays● Maintain
Equal Weight
2025-10-22Truist Securities● Maintain
Hold
2025-10-22Earnings History & Surprises
BEAT RATE
100%
Last 18 quarters
AVG SURPRISE
+5.5%
EPS vs Estimate
BEATS / MISSES
18/0
Last 18 quarters
LATEST EPS
$2.42
Q1 '26
QUARTERLY EPS TREND
Estimated
Beat
Miss
QUARTERLY DETAIL
Q1 '26
+2.5%
$2.42 vs $2.36
Q4 '25
+4.0%
$2.60 vs $2.50
Q3 '25
+1.9%
$2.62 vs $2.57
Q2 '25
+2.8%
$2.21 vs $2.15
Q1 '25
+1.8%
$2.23 vs $2.19
Q4 '24
+1.8%
$2.30 vs $2.26
Q3 '24
+0.4%
$2.35 vs $2.34
Q2 '24
+9.7%
$2.04 vs $1.86
Q1 '24
+1.9%
$2.15 vs $2.11
Q4 '23
+1.4%
$2.22 vs $2.19
Q3 '23
+1.3%
$2.30 vs $2.27
Q2 '23
+3.6%
$2.04 vs $1.97
No investor questions available.
Latest News
No news available